KemPharm Prices $75M Private Bond After Nixing Follow-On
KemPharm Inc., a developer of addiction-resistant pain medication, on Thursday priced a private placement of $75 million in notes to repay debt and develop its pipeline one day after withdrawing a...To view the full article, register now.
Already a subscriber? Click here to view full article